Philip D. King

4.4k citations

76 papers · 3.5k indexed · 1 hit paper · h-index 34

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Immunology and Allergy top 2%
- Cell Adhesion Molecules Research

Papers in

Immunology 38
- Immune Cell Function and Interaction 27
- T-cell and B-cell Immunology 25
- Immunotherapy and Immune Responses 8
- Galectins and Cancer Biology 7
Aging 2

Co-authors: Philip E. Lapinski Francesc Martí David R. Katz Bo Dupont Michel Sadelain Clay Lyddane Beth A. Lubeck Elmer Santos
Journals: The Journal of Immunology (12 papers)Proceedings of the National Academy of Sciences (6 papers)The Journal of Experimental Medicine (4 papers)Journal of Clinical Investigation (3 papers)European Journal of Immunology (3 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Philip D. King

73 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 2003 · 513 citations

Peers

Countries citing papers authored by Philip D. King

Since Specialization

Citations

This map shows the geographic impact of Philip D. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. King more than expected).

Fields of papers citing papers by Philip D. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. King. The network helps show where Philip D. King may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip D. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip D. King Line = papers co-authored together Philip D. King links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Macropinosomes are a site of HIV-1 entry into primary CD4 ⁺ T cells Proceedings of the National Academy of Sciences ·Tomoyuki Murakami, Charles Ndikumana, D Das Sarma, Ya-Ting Chang, Hyungdon Kook, Keng C. Chou, Yixin Tang, Joel A. Swanson, Philip D. King, Akira Ono	2025	1
2	Transport and Immune Functions of the Lymphatic System Annual Review of Physiology ·Michael J. Davis, Scott D. Zawieja, Philip D. King	2024	4
3	EPHB4-RASA1 Inhibition of PIEZO1 Ras Activation Drives Lymphatic Valvulogenesis Circulation Research ·Y Yaherwandi, Yixin Tang, Philip E. Lapinski, David K. Wiggins, Eva M. Sevick‐Muraca, Michael J. Davis, Philip D. King	2024	7
4	Angiogenesis depends upon EPHB4-mediated export of collagen IV from vascular endothelial cells JCI Insight ·Di Chen, Elizabeth D. Hughes, Thomas L. Saunders, Jiangping Wu, Marcela Perenguez, Taija Mäkinen, Philip D. King	2022	19
5	RASA1-driven cellular export of collagen IV is required for the development of lymphovenous and venous valves in mice Development ·Di Chen, Xin Geng, Philip E. Lapinski, Michael J. Davis, R. Sathish Srinivasan, Philip D. King	2020	17
6	Simplified method to quantify valve back‐leak uncovers severe mesenteric lymphatic valve dysfunction in mice deficient in connexins 43 and 37 The Journal of Physiology ·Jorge A. Castorena‐Gonzalez, R. Sathish Srinivasan, Philip D. King, Alexander M. Simon, Michael J. Davis	2020	19
7	RASA1-dependent cellular export of collagen IV controls blood and lymphatic vascular development Journal of Clinical Investigation ·Di Chen, Joyce Teng, Paula E. North, Philip E. Lapinski, Philip D. King	2019	48
8	Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling Blood ·Katarzyna Mleczko‐Sanecka, Cemgir Akdemir, Kwonyoung Jung, Ahmad Ibrahim Hasibuan, Flavia D’Alessio, Anan Ragab, Philip E. Lapinski, Ramesh Ummanni, Ulrike Korf, Christopher C. Oakes, Georg Damm, Lorenza A. D’Alessandro, Ursula Klingmüller, Philip D. King, Michael Boutros, Matthias W. Hentze, Martina U. Muckenthaler	2014	59
9	Regulation of bone and skeletal development by the SHP-2 protein tyrosine phosphatase Bone ·Nobuhiro Kamiya, Harry K.W. Kim, Philip D. King	2014	14
10	Lymphatic vessel abnormalities arising from disorders of Ras signal transduction Trends in Cardiovascular Medicine ·Eva M. Sevick‐Muraca, Philip D. King	2013	26
11	MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis Nature Medicine ·Sudarshan Anand, Bharat K. Majeti, Lisette M. Acevedo, Eric A. Murphy, Rajesh Mukthavaram, Lea Scheppke, Miller Huang, David J. Shields, Jeffrey N. Lindquist, Philip E. Lapinski, Philip D. King, Sara M. Weis, David A. Cheresh	2010	418
12	Normal TCR Signal Transduction in Mice That Lack Catalytically Active PTPN3 Protein Tyrosine Phosphatase The Journal of Immunology ·Timothy J. Bauler, Elizabeth D. Hughes, Yutaka Arimura, Tomas Mustelin, Thomas L. Saunders, Philip D. King	2007	22
13	The T Cell-Specific Adapter Protein Functions as a Regulator of Peripheral but not Central Immunological Tolerance Advances in experimental medicine and biology ·Philip E. Lapinski, Hans-Jürgen Muskulus, Francesc Martí, Philip D. King	2007	4
14	Cutting Edge: CD28 Controls Dominant Regulatory T Cell Activity during Active Immunization The Journal of Immunology ·Clay Lyddane, Beata Gajewska, Elmer Santos, Philip D. King, Gláucia C. Furtado, Michel Sadelain	2006	14
15	The p95-100kDa ligand of the T cell-specific adaptor (TSAd) protein Src-homology-2 (SH2) domain implicated in TSAd nuclear import is p97 Valosin-containing protein (VCP) Immunology Letters ·Francesc Martí, Philip D. King	2004	17
16	ICAM‐1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G European Journal of Immunology ·Olivier Robledo, Anne Papaioannou, Martha O'Nan, E G Mize, A Kotan, André M. Cantin, Philip D. King, Claude Daniel, Valery Yu. Alakhov, Édouard F. Potworowski, Yves St‐Pierre	2003	58
17	Negative-Feedback Regulation of CD28 Costimulation by a Novel Mitogen-Activated Protein Kinase Phosphatase, MKP6,. The Journal of Immunology ·Francesc Martí, Anja Krause, Nicholas H. Post, Clay Lyddane, Bo Dupont, Michel Sadelain, Philip D. King	2001	94
18	Cutting Edge: T Cell-Specific Adapter Protein Inhibits T Cell Activation by Modulating Lck Activity The Journal of Immunology ·Vibeke Sundvold, Knut Martin Torgersen, Nicholas H. Post, Francesc Martí, Philip D. King, Huei Yu Huang, Anne Spurkland, Tor Lea	2000	46
19	CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail International Immunology ·Philip D. King	1998	16
20	Human tonsillar dendritic cell‐induced T cell responses: analysis of molecular mechanisms using monoclonal antibodies European Journal of Immunology ·Philip D. King, David R. Katz	1989	64

About Philip D. King

Philip D. King is a scholar working on Immunology, Aging, Immunology and Allergy, Oncology and Cell Biology, having authored 76 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (27 papers), T-cell and B-cell Immunology (25 papers), Protein Tyrosine Phosphatases (11 papers), Lymphatic System and Diseases (9 papers), Immunotherapy and Immune Responses (8 papers), Cytokine Signaling Pathways and Interactions (8 papers), Galectins and Cancer Biology (7 papers) and Vascular Malformations and Hemangiomas (6 papers). The work is most often cited by research in Immunology (1.4k citations), Immunology and Allergy (269 citations), Oncology (1.1k citations), Cancer Research (440 citations) and Molecular Biology (1.5k citations). Philip D. King has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Philip E. Lapinski, Francesc Martí, David R. Katz, Bo Dupont, Michel Sadelain, Clay Lyddane, Beth A. Lubeck, Elmer Santos, Steven M. Larson and Isabelle Rivière. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, Journal of Clinical Investigation and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact